会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 24. 发明申请
    • SYSTEMS AND METHODS FOR MONITORING EFFECTIVENESS OF CONGESTIVE HEART FAILURE THERAPY
    • 用于监测心脏失效治疗有效性的系统和方法
    • US20080183083A1
    • 2008-07-31
    • US11669396
    • 2007-01-31
    • H. Toby MarkowitzSameh Sowelam
    • H. Toby MarkowitzSameh Sowelam
    • A61B5/0205A61N1/36
    • A61B5/6826A61B5/0285A61B5/042A61B5/053A61B5/08A61B5/14551A61B5/4818A61B5/6838
    • A method for monitoring a patient includes measuring a series of consecutive pulse transit times (PTT's) of the patient, and processing the resulting PTT signal to detect a presence or absence of central sleep apnea (CSA). The method further includes determining an effectiveness of congestive heart failure therapy, which is being provided to the patient, based on the detected presence or absence of CSA. A system incorporating the method includes an electrode of an implantable medical device, which is adapted to pick up the patient's ventricular depolarization signals, a sensor, which is adapted to pick up peripheral arterial pulse signals of the patient, and a signal processor, which is adapted to receive the two types of signals and to process the signals according to the method. The system may provide the therapy via cardiac resynchronization pacing and, upon detection of CSA, the system may adjust at least one pacing parameter.
    • 用于监测患者的方法包括测量患者的一系列连续脉冲传递时间(PTT),并且处理所得到的PTT信号以检测中枢性睡眠呼吸暂停(CSA)的存在或不存在。 该方法还包括基于检测到的CSA的存在或不存在来确定正在提供给患者的充血性心力衰竭治疗的有效性。 包括该方法的系统包括可植入医疗装置的电极,其适于拾取患者的心室去极化信号,适于拾取患者的外周动脉脉冲信号的传感器,以及信号处理器,其是 适于接收两种类型的信号并根据该方法处理信号。 系统可以通过心脏再同步起搏提供治疗,并且在检测到CSA时,系统可以调整至少一个起搏参数。
    • 25. 发明授权
    • Apparatus and method for detecting micro-dislodgment of a pacing lead
    • 用于检测起搏引线的微移位的装置和方法
    • US06445952B1
    • 2002-09-03
    • US09573507
    • 2000-05-18
    • Christopher M. ManrodtH. Toby MarkowitzBradley C. Peck
    • Christopher M. ManrodtH. Toby MarkowitzBradley C. Peck
    • A61N108
    • A61N1/37A61N1/37241A61N2001/083
    • An apparatus and method for detecting micro-dislodgment at a heart tissue/pacing lead electrode interface involves measuring a first pacing threshold parameter at a first time in a patient's cardiac cycle and measuring a second pacing threshold parameter at a second time in the patient's cardiac cycle. Micro-dislodgment occurring at the heart tissue/pacing lead electrode interface is detected using the first and second pacing threshold parameters. Micro-dislodgment may be detected by comparing a difference between, or a ratio of, the first and second pacing threshold parameters to a preestablished maximum allowable deviation value. A difference between the first and second pacing threshold parameters or a ratio in excess of the preestablished maximum allowable deviation value indicates a problem at the heart tissue/pacing lead interface. The first and second pacing threshold parameters are preferably pacing threshold voltages, and the preestablished maximum allowable deviation value is either a voltage ranging from about 0.2 volts to about 2 volts or a percentage ranging from about 5% to about 100%. The micro-dislodgment procedure may be performed in-situ an implantable pulse generator (IPG), with data indicative of a detected change at the heart tissue/pacing electrode interface being stored in a memory coupled to the IPG and subsequently read out of memory for evaluation. Alternatively, the micro-dislodgment procedure may be performed using an external programmer and may further be performed during implantation of a pacing lead electrode at the heart tissue/pacing lead electrode interface to assure a physician of proper lead attachment.
    • 用于检测心脏组织/起搏引线电极界面处的微移位的装置和方法包括在患者的心动周期中第一时间测量第一起搏阈值参数,并在患者的心动周期中第二时间测量第二起搏阈值参数 。 使用第一和第二起搏阈值参数检测在心脏组织/起搏引线电极界面处发生的微移动。 可以通过将第一和第二起搏阈值参数之间的差值或比例与预先建立的最大允许偏差值进行比较来检测微移动。 第一和第二起搏阈值参数之间的差异或超过预先建立的最大允许偏差值的比值表示在心脏组织/起搏引线界面处的问题。 第一和第二起搏阈值参数优选为起搏阈值电压,并且预先建立的最大允许偏差值是约0.2伏特至约2伏范围内的电压或约5%至约100%的百分比。 微移动程序可以原位执行可植入脉冲发生器(IPG),其中指示心脏组织/起搏电极界面上检测到的变化的数据被存储在耦合到IPG的存储器中,随后读出存储器 评估。 或者,可以使用外部编程器执行微移动过程,并且可以在心脏组织/起搏引线电极界面处植入起搏引线电极期间进一步执行微移动过程,以确保医生适当的引线附着。
    • 27. 发明授权
    • Dual chamber pacing system and method with optimized adjustment of the
AV escape interval for treating cardiomyopathy
    • 双室起搏系统和方法优化AV治疗心肌病逃逸间隔的调整
    • US5514163A
    • 1996-05-07
    • US391947
    • 1995-02-21
    • H. Toby MarkowitzTom D. Bennett
    • H. Toby MarkowitzTom D. Bennett
    • A61N1/368A61N1/362
    • A61N1/3627A61N1/3682
    • A dual chamber pacemaker system and method are provided for HOCM and like pacing therapy, with the feature of searching or scanning values of AV escape interval to define an optimized value at about the longest AV escape interval value consistent with full capture in response to a delivered ventricular pace pulse. In a preferred embodiment of the invention, the system and method sense and process FFRS signals derived from the atrial lead and otherwise, and obtain therefrom a characteristic which is evaluated for a determination of optimized AV escape interval. In one specific embodiment, the time durations between delivered ventricular pacing pulses and resulting FFRS signals are analyzed as a function of AV escape interval, and the optimized AV escape interval is chosen at about the longest AV escape interval corresponding to the longest such time duration, i.e., at about the knee of the FFRS time duration vs. AV escape interval curve. In another embodiment, the FFRS characteristic utilized is duration, and the system determines the longest AV escape interval corresponding to the highest duration value. The system and method can be utilized either with an external programmer or can be adapted to operate automatically in an implanted pacemaker.
    • 为HOCM和类似起搏治疗提供双室起搏器系统和方法,具有搜索或扫描AV逃逸间隔值的特征,以在与所传送的全部捕获相一致的大多数AV逃逸间隔值下定义优化值 心室起搏脉搏。 在本发明的优选实施例中,系统和方法感测和处理从心房线导出的FFRS信号,否则获得被评估用于确定优化的AV逃逸间隔的特性。 在一个具体实施例中,作为AV逃逸间隔的函数分析递送的心室起搏脉冲和所产生的FFRS信号之间的时间持续时间,并且在对应于最长的这样的持续时间的大约最长的AV逃逸间隔中选择优化的AV逃逸间隔, 即,在FFRS持续时间与AV逃逸间隔曲线的大约膝盖处。 在另一个实施例中,所使用的FFRS特征是持续时间,并且系统确定对应于最高持续时间值的最长的AV逃逸间隔。 该系统和方法可以与外部编程器一起使用,或者可以适用于在植入式心脏起搏器中自动操作。
    • 28. 发明授权
    • Apnea stimulation lead
    • 呼吸暂停刺激引线
    • US5238006A
    • 1993-08-24
    • US719929
    • 1991-06-24
    • H. Toby Markowitz
    • H. Toby Markowitz
    • A61N1/05A61N1/36
    • A61N1/0519A61N1/0548A61N1/3601
    • A stimulation lead for electrically coupling an implantable pulse generator to an electrode in an apnea treatment system and method of making same. The lead employs a thin substrate of polyurethane or other highly flexible implantable material. Conductors are placed on the substrate by silk screening a conductive ink. The ends of the lead are electrically terminated using rivets which couple through the substrate. The substrate is folded to enclose the conductors, thereby insulating them and protecting them from bodily fluids. Suitable connectors may be attached to either end. The resulting lead is easily fabricated and is extremely thin and flexible.
    • 刺激引线,用于将植入式脉冲发生器电耦合到呼吸暂停治疗系统中的电极及其制造方法。 铅使用聚氨酯或其他高度柔性可植入材料的薄基材。 通过丝网印刷导电油墨将导体放置在基材上。 引线的端部使用铆接在基板上的铆钉进行电气端接。 将基板折叠以包围导体,从而使其绝缘并保护它们免于体液。 合适的连接器可以连接到任一端。 所得到的引线易于制造,并且非常薄且灵活。
    • 29. 发明授权
    • Atrial refractory control for R-wave rejection in pacemakers
    • 心房起搏器R波消除的心房难治性控制
    • US4343311A
    • 1982-08-10
    • US145052
    • 1980-04-30
    • H. Toby Markowitz
    • H. Toby Markowitz
    • A61N1/368A61N1/362A61N1/365A61N1/36
    • A61N1/3622
    • An artificial heart pacemaker and control circuit having an atrial synchronous pacing mode includes an output pulse generator for delivering stimulating pulses to the ventricle of the heart, and atrial and ventricular sensing amplifiers for detecting, respectively, atrial and ventricular contractions. The atrial sense amplifier starts an A-V delay timer which provides a delayed triggering pulse to the pulse generator to maintain A-V synchrony. Circuitry is provided for blanking or turning off the atrial sensing amplifier during the time that the ventricular sensing amplifier is refractory, and preferably for a short time interval thereafter, to prevent delivery of an output pulse in response to a premature ventricular contraction erroneously sensed as an atrial contraction.
    • 具有心房同步起搏模式的人造心脏起搏器和控制电路包括用于将刺激脉冲输送到心脏心室的输出脉冲发生器,以及分别用于检测心房和心室收缩的心房和心室感测放大器。 心律感知放大器启动A-V延迟定时器,为脉冲发生器提供延迟的触发脉冲以保持A-V同步。 提供电路用于在心室感测放大器难治的时间期间消隐或关闭心房感测放大器,并且优选地在此之后的短时间间隔内,以防止输出脉冲响应于错误地感测为过早的心室收缩 心房收缩。